Search by Drug Name or NDC
NDC 70121-1654-01 Triamcinolone Acetonide 200 mg/5mL Details
Triamcinolone Acetonide 200 mg/5mL
Triamcinolone Acetonide is a INTRA-ARTICULAR; INTRAMUSCULAR INJECTION, SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals LLC. The primary component is TRIAMCINOLONE ACETONIDE.
Product Information
| NDC | 70121-1654 |
|---|---|
| Product ID | 70121-1654_96c0858b-8b74-4e04-8929-5507c5432445 |
| Associated GPIs | 22100050101810 |
| GCN Sequence Number | 006795 |
| GCN Sequence Number Description | triamcinolone acetonide VIAL 40 MG/ML INJECTION |
| HIC3 | P5A |
| HIC3 Description | GLUCOCORTICOIDS |
| GCN | 27452 |
| HICL Sequence Number | 002891 |
| HICL Sequence Number Description | TRIAMCINOLONE ACETONIDE |
| Brand/Generic | Generic |
| Proprietary Name | Triamcinolone Acetonide |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Triamcinolone Acetonide |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SUSPENSION |
| Route | INTRA-ARTICULAR; INTRAMUSCULAR |
| Active Ingredient Strength | 200 |
| Active Ingredient Units | mg/5mL |
| Substance Name | TRIAMCINOLONE ACETONIDE |
| Labeler Name | Amneal Pharmaceuticals LLC |
| Pharmaceutical Class | Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA207550 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 70121-1654-01 (70121165401)
| NDC Package Code | 70121-1654-1 |
|---|---|
| Billing NDC | 70121165401 |
| Package | 1 VIAL, MULTI-DOSE in 1 CARTON (70121-1654-1) / 5 mL in 1 VIAL, MULTI-DOSE |
| Marketing Start Date | 2017-12-11 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 6.67133 |
| Pricing Unit | ML |
| Effective Date | 2023-07-19 |
| NDC Description | TRIAMCINOLONE ACET 200 MG/5 ML |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4, 5 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis